Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis

Area of Science:

• Genetics
• Immunology
• Medical Research

Background:

• Sarcoidosis shares immunological genes with other immune-mediated diseases.
• Specific HLA haplotypes (HLA-DRB1*03:01 and/or HLA-DRB1*04:01-DPB1*04:01) are associated with good prognosis in Finnish sarcoidosis patients.
• No genetic markers for persistent sarcoidosis have been identified.

Purpose of the Study:

• To identify genetic differences between sarcoidosis prognosis subgroups, particularly in relation to HLA markers.
• To pinpoint genetic variations associated with resolved versus persistent sarcoidosis.
• To validate previously identified genetic associations.

Main Methods:

• Whole-exome sequencing (WES) was performed on 72 Finnish sarcoidosis patients stratified by disease activity (resolved vs. persistent) and HLA marker status.
• Finnish exome data from the Genome Aggregation Database served as a control population.
• Statistical analyses included single-variant and gene-level analyses, with replication in an independent cohort of 181 sarcoidosis patients and 150 controls.

Main Results:

• A significant association was found on chromosome 1p36.21 (genes AADACL3 and C1orf158) with resolved sarcoidosis (p-values < 0.0004).
• These genetic variations in AADACL3 and C1orf158 were previously linked to sarcoidosis in another WES study.
• An association with the Leucocyte Receptor Complex in 19q13.42 was observed but did not hold in the replication sample.

Conclusions:

• This WES study confirms the association of the 1p36.21 region (AADACL3, C1orf158) with sarcoidosis prognosis.
• The findings support the role of these genes in sarcoidosis, particularly in patients with resolved disease.
• Further research is needed to validate the novel genetic region identified and its potential role in sarcoidosis.